Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C.
de Lédinghen V, Trimoulet P, Winnock M, Foucher J, Bourlière M, Desmorat H, Canva V, Capron D, Lévy S, Mion F, Mannant PR, Chêne G, Fleury H, Couzigou P, Bernard PH; French Multicenter Study Group. de Lédinghen V, et al. Among authors: canva v. J Hepatol. 2002 May;36(5):672-80. doi: 10.1016/s0168-8278(02)00026-0. J Hepatol. 2002. PMID: 11983451 Clinical Trial.
[Treatment of chronic hepatitis C and alcohol consumption].
Mathurin P, Canva V, Dharancy S, Paris JC. Mathurin P, et al. Among authors: canva v. Gastroenterol Clin Biol. 2002 Apr;26 Spec No 2:B248-51. Gastroenterol Clin Biol. 2002. PMID: 12180297 Review. French. No abstract available.
Evaluation of amantadine in chronic hepatitis C: a meta-analysis.
Deltenre P, Henrion J, Canva V, Dharancy S, Texier F, Louvet A, De Maeght S, Paris JC, Mathurin P. Deltenre P, et al. Among authors: canva v. J Hepatol. 2004 Sep;41(3):462-73. doi: 10.1016/j.jhep.2004.05.019. J Hepatol. 2004. PMID: 15336450
Histological response in patients treated by interferon plus ribavirin for hepatitis C virus-related severe fibrosis.
Abergel A, Darcha C, Chevallier M, Ughetto S, Henquell C, Pol S, de Ledinghen V, Canva V, Bronowicki JP, Tran A, Martineau N, Lafeuille H, Dechelotte P, Bommelaer G, Bonny C; French Multicentre Study Group. Abergel A, et al. Among authors: canva v. Eur J Gastroenterol Hepatol. 2004 Nov;16(11):1219-27. doi: 10.1097/00042737-200411000-00022. Eur J Gastroenterol Hepatol. 2004. PMID: 15489585 Clinical Trial.
Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection.
Dharancy S, Malapel M, Perlemuter G, Roskams T, Cheng Y, Dubuquoy L, Podevin P, Conti F, Canva V, Philippe D, Gambiez L, Mathurin P, Paris JC, Schoonjans K, Calmus Y, Pol S, Auwerx J, Desreumaux P. Dharancy S, et al. Among authors: canva v. Gastroenterology. 2005 Feb;128(2):334-42. doi: 10.1053/j.gastro.2004.11.016. Gastroenterology. 2005. PMID: 15685545
Characteristics of patients with chronic hepatitis B in France: predominant frequency of HBe antigen negative cases.
Zarski JP, Marcellin P, Leroy V, Trepo C, Samuel D, Ganne-Carrie N, Barange K, Canva V, Doffoel M, Cales P; Fédération nationale des Pôles de référence et des Réseaux Hépatites. Zarski JP, et al. Among authors: canva v. J Hepatol. 2006 Sep;45(3):355-60. doi: 10.1016/j.jhep.2006.03.007. Epub 2006 Apr 18. J Hepatol. 2006. PMID: 16750585
Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: a case-control study.
Dharancy S, Boitard J, Decaens T, Sergent G, Boleslawski E, Duvoux C, Vanlemmens C, Meyer C, Gugenheim J, Durand F, Boillot O, Declerck N, Louvet A, Canva V, Romano O, Ernst O, Mathurin P, Pruvot FR. Dharancy S, et al. Among authors: canva v. Liver Transpl. 2007 May;13(5):665-71. doi: 10.1002/lt.21109. Liver Transpl. 2007. PMID: 17427172 Free article. Clinical Trial.
78 results